Regulatory PathRegulatory requirements compared

Active substances

Hydrochlorothiazide + Quinapril

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ACCUZIDE 20 F.C.TAB20, 12.5 mgFilm-coated tablet · Oral use30 BlisterSAR 23.30NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASEtablet · oralCHARTWELL RXPrescription31 Mar 2004
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASEtablet · oralAUROBINDO PHARMAPrescription24 Aug 2007
ACCURETIC12.5MG;EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 12.5MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 25MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**tablet · oralPFIZER PHARMSDiscontinued28 Dec 1999
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASEtablet · oralPHARMOBEDIENTDiscontinued28 Mar 2005
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASEtablet · oralSUN PHARM INDS LTDDiscontinued4 Mar 2009
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASEtablet · oralINVAGEN PHARMSDiscontinued20 Apr 2011
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASEtablet · oralAPOTEXDiscontinued12 Mar 2013

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
APO-QUINAPRIL/HCTZ0240876712.5 MG; 10 MGTABLET · ORALAPOTEX INC
APO-QUINAPRIL/HCTZ0240877512.5 MG; 20 MGTABLET · ORALAPOTEX INC
APO-QUINAPRIL/HCTZ0240878320 MG; 25 MGTABLET · ORALAPOTEX INC
AURO-QUINAPRIL HCTZ0247329112.5 MG; 10 MGTABLET · ORALAURO PHARMA INC
AURO-QUINAPRIL HCTZ0247330512.5 MG; 20 MGTABLET · ORALAURO PHARMA INC
AURO-QUINAPRIL HCTZ0247332125 MG; 20 MGTABLET · ORALAURO PHARMA INC
JAMP QUINAPRIL / HCTZ0254743010 MG; 12.5 MGTABLET · ORALJAMP PHARMA CORPORATION
JAMP QUINAPRIL / HCTZ0254744920 MG; 25 MGTABLET · ORALJAMP PHARMA CORPORATION

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.